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Abstract The effect of insulin and epidermal growth factor on the phosphorylation f CTP: phosphocholine cytidylyltransferase (EC 2.7.7.15) was 
investigated in HeLa ceils. For the first time, cytidylyltransferase phosphorylation was shown to be influenced by growth factors in cell culture 
experiments. The rephosphorylation of cytidylyltransferase after an oleate-mediated dephosphorylation and translocation to membranes was 
increased after 2 min in the presence of insulin or epidermal growth factor by 99% and 76%, respectively, compared with controls. However, the 
increased phosphorylation f cytidylyltransferase did not have an effect on its subcellular distribution. Furthermore, purified cytidylyltransferase 
preincubated with alkaline phosphatase is a substrate for p44 mapk, amember of the mitogen-activated protein (MAP) kinase family downstream of 
the growth factor eceptors, in vitro. In accordance with the in vivo data, in vitro phosphorylation f cytidylyltransferase by p44 ~apk occurred after 
2 min. 
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1. ~u~on 
Phosphatidylcholine (PC) is the most abundant phospholipid 
in mammalian cell membranes, playing an important role in 
both membrane structure and signal transduction [1]. In these 
cells PC is synthesized mainly by the CDP-choline pathway, for 
which CTP:phosphocholine cytidylyltransferase (EC 2.7.7.15) 
(CT) is a rate-limiting enzyme [2-4]. An important regulatory 
mechanism for the control of CT activity is the translocation 
of the enzyme between cytosol and membranes, especially in 
HeLa cells [5,6]. In most cases the cytosolic form of CT appears 
to be an inactive reservoir which can be translocated reversibly 
to membranes, where it becomes activated by interaction with 
phospholipids in the membrane [7]. The translocation process 
can be modulated by various signals [for review see 8] and the 
involvement of reversible phosphorylation has been discussed 
[9-1 l]. 
Concerning the kinases that phosphorylate CT there exists 
some controversy. Whereas CT is a substrate for cAMP-de- 
pendent protein kinase (PKA) in vitro [12], neither PKA nor 
protein kinase C (PKC) seem to phosphorylate CT in vivo 
[13-17]. In rat hepatocytes and HeLa cells only serine-residues 
of CT are phosphorylated in vivo [15,17]. The cDNA of rat liver 
CT shows repeated serine/proline-rich domains [18], resembling 
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potential phosphorylation sites for proline-directed protein ki- 
nases like mitogen-activated protein kinases (MAP kinases) 
[19,20] or cyclin-dependent protein kinases [21]. Recently, most 
of these serines were identified to be phosphorylated in vivo 
[22]. MAP kinases, also described as extracellular signal-regu- 
lated kinases (ERK), comprise a family of serine/threonine 
protein kinases conserved through evolution in all eukaryotic 
cells, that participate in signal transduction pathways initiated 
by many extraceUular stimuli [23]. In HeLa cells, two highly 
related mammalian MAP kinase isoforms, p44 mapk and p42 mapk, 
are activated within minutes in response to growth factors [24]. 
In the present study, we demonstrate that growth factors 
stimulate CT phosphorylation i  HeLA cells. Since MAP ki- 
nases are known to be activated in response to growth factors 
in HeLa cells, we tested if a typical MAP kinase (p44 mapk) 
phosphorylates CT in vitro. After dephosphorylation f puri- 
fied CT, we observe an incorporation of phosphate into CT 
catalyzed by p44 mapk in a time- and dose-dependent manner. 
2. Materials and methods 
2.1. Materials 
[methyl-14C]Phosphocholine (2.04 GBq/nmol), [y32p]ATP and the 
ECL immunoblotting detection reagent were from Amersham (Braun- 
schweig, Germany). Carrier-free 32PO 4 (10 mCi/ml) was purchased from 
DuPont (Bad Homburg, Germany). Digitonin, fatty acid-free bovine 
serum albumin (BSA), agarose-conjugated alkaline phosphatase, anti- 
phosphotyrosine monoclonal mouse antibody, insulin from bovine 
pancreas, epidermal growth factor (EGF) from mouse submaxillary 
glands, protein A-Sepharose, and oleic acid were from Sigma 
(Miinchen, Germany). Silicage160 high-performance thin-layer chrom- 
atography plates and reagents were purchased from Merck (Darmstadt, 
Germany). For quantification of radioactivity a radioscanner (LB2821 
HR; Berthold, Wildbad, Germany) was used. Peroxidase-conjugated 
swine anti-rabbit antibody was from Dakopatts (Hamburg, Germany) 
and the nitrocellulose-membrane (0.45/tm) was from Schleicher and 
Schiill (Dassel, Germany). MAP kinase (p44 rnapk, purified enzyme from 
sea star) was purchased from UBI (Lake Placid, New York, USA). 
Polyclonal antibodies were raised against two peptide fragments of CT 
(CT peptide 1-17 and CT peptide 247-257) according to the cDNA 
published by Kalmar et al. [18], as described and characterized [25]. 
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2.2. Cell culture 
HeLa cells were grown in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% heat-inactivated fetal calf serum 
(FCS), 0.58 g/1 glutamine, 110 000 units/l penicillin and 0.1 g/l strepto- 
mycin in plastic culture dishes (Nunc, Denmark). Media and culture 
reagents were from Gibco (Karlsruhe, Germany) and antibiotics from 
Boehringer (Mannheim, Germany). Confluent cells were further cul- 
tured in DMEM containing 0.5% FCS for 30 h prior to experiments 
with growth factors. 
2.3. Solutions 
PBS buffer contained 150 mM NaCI, 3 mM KCI, 8 mM Na2HPO 4 
and 1 mM KHePO4, pH 7.2. A 100 mM oleate stock solution was 
prepared in 0.12 M KOH containing 95% ethanol as described [6]. For 
oleate treatment, the ethanol was evaporated under N2 gas and the fatty 
acid was resuspended in 0.33% fatty acid free BSA in DMEM or 
phosphate-free DMEM (for the in vivo 32p-labeling experiments), on- 
icated in a bath sonicator for 10 min and used immediately. 
2.4. 32p-labeling ofcells 
HeLa cells were grown to confluence in 60 mm-diameter dishes. The 
serum-starved cells were washed twice with 5 ml of phosphate-free 
DMEM and then incubated for 2 h in 2 ml of the same medium 
containing 1 mCi of carrier-free 32po 4 and 0.33% BSA. At that time 
0.5 ml oleate-containing medium was added to a final concentration f 
0.5 mM. After 1 h preincubation, the medium was removed and the 
cells were washed twice with 5 ml PBS. The test medium, containing 
the indicated growth factors and 0.33% fatty acid free BSA, was added 
for 2 min. The dishes were washed twice with ice-cold PBS, and the cells 
were fractionated by treatment with digitonin release buffer as de- 
scribed in the next section. 
2.5. Digitonin permeabilization f cells 
Cells were incubated with digitonin release buffer containing 50 mM 
Tris-HCl, pH 7.4, 0.25 M sucrose, 0.8 mg/ml digitonin, 50 mM NaF, 
50 /tM sodium vanadate, 3.3 mM EDTA, 3.3 mM EGTA, 1 mM 
phenylmethylsulfonyl fluoride, 2 gg/ml leupeptin, 2/tg/ml aprotinin 
and 2 gg/ml pepstatin for 2 min at 4°C. The soluble and particulate 
fractions of cells were separated as described previously [16]. 
2.6. Immunoblotting 
For phosphotyrosine immunoblotting stimulated cells were lysed by 
sonication in 200/tl of 50 mM HEPES, pH 7.4, 150 mM NaCI, 1% 
Triton X-100, 0.5% sodium deoxycholate, 5 mM EDTA, 50/zM sodium 
vanadate, 50 mM NaF, 1 mM phenylmethylsulfonyl fluoride (PMSF), 
2 gg/ml leupeptin, 2gg/ml aprotinin and 2 gg/ml pepstatin. Insoluble 
material was removed by centrifugation at 13,000 × g for 5 min at 4 ° C. 
The protein samples were mixed with SDS sample buffer [26] and 
separated by 10% SDS-PAGE. After transfer to nitrocellulose mem- 
brane the blot was incubated with 5% non-fat dry milk in PBS for 1 h 
at room temperature to block non-specific binding. The membrane was 
then incubated with a monoclonal anti-phosphotyrosine antibody 
(1:2500, Sigma) in PBS containing 0.1% Tween 20 over- 
night at 4°C. After washing three times for 5 min with PBS/Tween 20 
the antibody reactions were detected using horseradish peroxidase- 
conjugated antibodies and the ECL chemiluminescent detection rea- 
gents according to the manufacturer's instructions. 
The same procedure was used to detect purified CT with an antise- 
rum against CT peptide 247-257. 
2.7. Immunoprecipitation of ze P-labeled cytidylyhransferase 
To immunoprecipitate CT, the soluble and particulate fractions (500 
gl each) obtained by digitonin treatment were preincubated 2 h at 4 ° C 
with 100 mg Sepharose CL-4B (Pharmacia) prewashed with buffer 1 (50 
mM Tris, pH 7.4, 150 mM NaC1, 1 mM EDTA, 1% Triton X-100, 0.1% 
SDS, 0.5% sodium deoxycholate) after which the sepharose was sedi- 
mented by centrifugation. 50 gl of antiserum against CT peptide 247- 
257 was incubated with 2 ml protein A-Sepharose in buffer l for 2 h 
at 4°C after which the antibody coupled protein A-Sepharose was 
sedimented by centrifugation a d incubated overnight at 4°C with the 
precleared supernatant of the first step. The protein A-Sepharose was 
centrifuged at 13,000 × g for 2 min, and the supernatant was discarded. 
Finally the Sepharose containing immunoprecipitant was washed three 
times with buffer 1, three times with buffer containing 50 mM Tris, 
pH 7.4, 1 M NaC1 and 0.1% Triton X-100 and one time with PBS. The 
washed Sepharose was boiled in 2-mercaptoethanol containing SDS gel 
sample buffer, to dissociate immunoprecipitant. The immunoprecipi- 
tated protein samples were separated on 10% SDS-PAGE and the dried 
gels were exposed to Kodak XAR-5 film for 72 h at -70°C. Protein 
bands were quantified by use of a videodensitometer (Fischer Biotech, 
Reiskirchen, Germany). 
2.8. CTP : phosphocholine cytidylyltransferase assay 
CT activity was measured by a modified method of Sohal and Cornell 
[27] as described previously [16]. One unit of enzyme activity is defined 
as 1 nmol of CDP-choline formed per min. 
2.9. In vitro phosphorylation fcytidylyltransferase 
CT was purified from rat liver as described [28]. 1/tg of purified CT 
was used in each reaction. Dephosphorylation f purified CT was 
achieved by treatment with 5 U of agarose-bound alkaline phosphatase 
in the presence of 50 mM Tris-HC1, pH 7.7 and 2 mM dithiothreitol 
(DTT) for 30 min at 37°C. Alkaline phosphatase was removed by 
centrifugation at 13,000 × g for 5 min. The phosphorylation reaction 
was performed in the presence of 15 mM MOPS, pH 7.2, 2 mM DTT, 
12.5 mM fl-glycerophosphate, 7.5mM MgCI2, 2 mM EGTA, 50 gM 
ATP containing D,-32p]ATP (specific radioactivity 2.5 ,uCi/nmol), 5mM 
NaF, 1 mM sodium vanadate and different amounts of purified MAP 
kinase (p44maPk). Mixtures were incubated for up to 2 h at 30°C. The 
reactions were stopped by adding SDS sample buffer and the mixtures 
were loaded on SDS-PAGE (10% acrylamide) and electrophoresed. In 
some experiments, CT was immunoprecipitated prior to electrophoresis 
using antiserum against CT peptide 1-17. The dried gels were exposed 
to Kodak XAR-5 film for 24 h at -70°C. 
3. Results and discussion 
3.1. The effect of insulin and EGF on the activation of MAP 
kinases 
It has been shown in HeLa cells that both MAP kinase 
isoforms, p42 mapk and p44 mapk become activated in response to 
growth factors within minutes [24]. To determine the time- 
dependent stimulation of protein tyrosine phosphorylat ion i
our system we incubated serum-starved HeLa cells with insulin 
or EGF  for different ime-periods. A rapid stimulation of tyro- 
sine phosphorylat ion of proteins in the 41~,4 kDa range (indi- 
cated by the arrow) takes place after 2 min of growth factor 
treatment (Fig. 1). This stimulation is sustained over a time 
period of 15 min. 
3.2. Rephosphorylation f  cytidylyltransferase in the presence of 
insulin and EGF 
To investigate the possible role of PKA or PKC in phospho- 
rylating CT different approaches have used cAMP-analogues 
kDa insulin EGF 
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Fig. 1. Time-dependent stimulation of 1M2 tyrosine phosphorylation in 
HeLa cells. Serum-starved HeLa cells were stimulated with insulin 
(100 nM) or EGF (100 ng/ml) for 1, 2 and 15 min. After lysing the cells 
by sonication 40 fig of cell lysate was analyzed by SDS-PAGE, and 
phosphotyrosine-containing proteins were identified by immunoblot- 
ting as described in section 2. Positions of molecular weight standards 
and p42 are indicated. The results shown are representative of three 
independent experiments. 
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Fig. 2. Effect of insulin and EGF on the phosphorylation f cyti- 
dylyltransferase. S rum-starved HeLa cells were incubated in phos- 
phate-free DMEM containing 1mCi/60 mm dish 32Pi (carrier-free) and 
0.33% fatty acid free BSA for 2 h. Oleate-containing medium was added 
to a final concentration f0.5 mM and the incubation was continued 
for 1 h. The medium was removed and the cells were washed twice with 
5 ml PBS. At this time the test medium containing 0.33% fatty acid free 
BSA and the indicated growth factors (100 nM insulin or 100 ng/ml 
EGF, respectively) was added for 2 rain. The cells were incubated with 
digitonin release buffer for 5 min and CT was immunoprecipitated 
using CT-peptide antiserum. The immunoprecipitated protein samples 
were separated by 10% SDS-PAGE and the gels were xposed to Kodak 
XAR-5 film for 72 h. This experiment was repeated twice with similar 
results. Phosphorylation f CT was quantified by densitometric video- 
scanning. 
[14], cholera toxin [15], the selective inhibitor of cAMP-depend- 
ent protein kinase (PKA) H-89 [16] or phorbol esters [13,17]. 
However, differences in the overall phosphorylation of CT 
could not be observed in any of these cases. Since cytosolic CT 
is already extensively phosphorylated in untreated HeLa cells, 
we used a different starting-point where CT is almost com- 
pletely dephosphorylated by incubation of cells with oleate for 
1 h. Then, the medium was removed and replaced by a medium 
containing 0.33% fatty acid free BSA and insulin or EGF, 
respectively. The rephosphorylation f cytosolic CT was in- 
creased after 2 min in the presence of insulin or EGF by 
99 + 20% and 76 + 15%, respectively, as compared with con- 
trois containing only BSA (Fig. 2). Membrane-associated CT 
is not phosphorylated at all, neither in treated nor in untreated 
cells (data not shown). 
3.3. The effect of insulin-lEGF-treatment on the subcellular 
distribution of  cytidylyltransferase 
Since a significant difference in the phosphorylation f cy- 
tosolic CT was observed 2min after oleate removal, the distri- 
bution of CT under these conditions was determined. The cy- 
tosolic and particulate fractions were separated by treatment 
with digitonin-release buffer and the activity of fully activated 
enzyme was measured inboth fractions. While 83.3 + 3% of CT 
is located in the cytosol in untreated cells almost the whole 
enzyme pool (95 + 2%) translocates to membranes following 
1 h incubation with 0.5 mM oleate. Two minutes after oleate 
removal 68.2 + 5% retranslocates back to the cytosol in con- 
trois and only slightly less does so in insulin- or EGF-treated 
cells (61.5 + 1% and 62.3 + 1.3%, respectively). Therefore, the 
increased phosphorylation of CT observed in insulin/EGF- 
treated cells does not significantly influence the distribution of 
the enzyme between cytosol and membranes. In this context, 
experimental evidence was provided by another group that the 
phosphorylated form of CT can bind to membranes [29]. 
3.4. Phosphorylation of  cytidylyltransferase by MAP kinase in 
vitro 
It was tested if CT is a substrate for MAP kinases in vitro 
for two reasons: first, the eDNA of rat liver CT contains poten- 
tial phosphorylation sites for proline-directed protein kinases 
and, second, growth factors are known to activate p42 mapk and 
p44 mapk within minutes, especially in HeLa cells [24]. CT was 
purified from rat liver cytosol and incubated with p44 mapk. The 
CT preparation did not contain any intrinsic protein kinase 
activity (Fig. 3, lane 1). After a preceding dephosphorylation 
of CT with alkaline phosphatase an incorporation fphosphate 
into CT catalyzed by p44 mapk in vitro was observed (Fig. 3, lane 
4) suggesting that most phosphorylation sites are already occu- 
pied in cytosolic CT from rat liver. The p44 mapk showed exten- 
sive autophosphorylation in the absence of CT as a substrate 
protein (Fig. 3, lane 2). Interestingly, autophosphorylation of 
p44 mapk was markedly reduced in the presence of CT. This 
might be due to competition ofthe phosphorylation sites of CT 
and p44 mapk. 
In another set of experiments, we used different amounts of 
p44 mapk to determine the optimum kinase concentration. 1 ng 
of pure p44 mapk per ~1 assay volume was found to be the most 
effective concentration (data not shown). 
3.5. Time course of incorporation of ~2P into cytidylyltransferase 
To further investigate the CT specificity of p44 mapk, a time 
course of 32p incorporation i to CT was performed using the 
optimum kinase concentration f I ng//tl. After 2 min of incu- 
bation CT was significantly phosphorylated, supporting our in 
vivo data that rephosphorylation of CT is very fast. The incor- 
poration of 32p into CT reached a plateau after 120 min 
(Fig. 4) with a stoichiometry of 0.15 mol phosphate per mol CT 
subunit. This substoichiometric in vitro phosphorylation is in 
accordance with results of other groups using PKA [12]. Fur- 
thermore, an additional slower migrating band appeared after 
10 min of incubation which might represent another form of 
CT containing a higher level of phosphorylation as reported 
previously [30,31]. However, the possibility that the slower 
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Fig. 3. Phosphorylation f cytidylyltransferase by MAP kinase in vitro. 
1 /zg CT was incubated with [7-32p]ATP in the absence (lane 1) or 
presence (lane 3) of p44 m~pk for 120 min at 30°C. Lane 2 represents the 
incubation of p44 mapk with [7-32P]ATP in the absence of CT and lane 
4 shows the incubation of [7-32p]ATP and p44 mapk with 1 pg CT that 
was initially dephosphorylated with alkaline phosphatase. The proteins 
were then analyzed on SDS-PAGE and the gel was exposed to autora- 
diography (a) as described in section 2. (b) Western blot showing CT 
probed with antiserum against CT peptide 247-257 (1 : 3000). 
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Fig. 4. Time-dependent phosphorylation of cytidylyltransferase by 
MAP kinase in vitro. Dephosphorylated CT was incubated with 
[7-32p]ATP in the presence of p44 m=pk (1 ng//ll assay volume) for differ- 
ent time intervals. CT was immunoprecipitated and subsequently ana- 
lyzed on SDS-PAGE as described in section 2 and a representative 
autoradiogram is shown. For stoichiometric calculations, bands corre- 
sponding to CT were excised from the gel and counted. 
migrating band represents a coprecipitated protein can not be 
excluded. 
In conclusion, we provide evidence that the phosphorylation 
of CT is connected with stimulation of cells by growth factors, 
supposedly through activation of MAP kinases. 
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